1. Home
  2. ASMB vs SHIM Comparison

ASMB vs SHIM Comparison

Compare ASMB & SHIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • SHIM
  • Stock Information
  • Founded
  • ASMB 2005
  • SHIM 1990
  • Country
  • ASMB United States
  • SHIM United States
  • Employees
  • ASMB N/A
  • SHIM N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • SHIM
  • Sector
  • ASMB Health Care
  • SHIM
  • Exchange
  • ASMB Nasdaq
  • SHIM Nasdaq
  • Market Cap
  • ASMB 84.5M
  • SHIM 75.7M
  • IPO Year
  • ASMB 2010
  • SHIM 2023
  • Fundamental
  • Price
  • ASMB $13.02
  • SHIM $2.20
  • Analyst Decision
  • ASMB Buy
  • SHIM Hold
  • Analyst Count
  • ASMB 2
  • SHIM 2
  • Target Price
  • ASMB $35.00
  • SHIM $3.00
  • AVG Volume (30 Days)
  • ASMB 22.1K
  • SHIM 11.3K
  • Earning Date
  • ASMB 03-27-2025
  • SHIM 03-27-2025
  • Dividend Yield
  • ASMB N/A
  • SHIM N/A
  • EPS Growth
  • ASMB N/A
  • SHIM N/A
  • EPS
  • ASMB N/A
  • SHIM N/A
  • Revenue
  • ASMB $28,326,000.00
  • SHIM $514,746,000.00
  • Revenue This Year
  • ASMB $282.16
  • SHIM N/A
  • Revenue Next Year
  • ASMB N/A
  • SHIM $3.01
  • P/E Ratio
  • ASMB N/A
  • SHIM N/A
  • Revenue Growth
  • ASMB N/A
  • SHIM N/A
  • 52 Week Low
  • ASMB $11.05
  • SHIM $1.47
  • 52 Week High
  • ASMB $19.93
  • SHIM $7.99
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 40.89
  • SHIM 38.01
  • Support Level
  • ASMB $12.10
  • SHIM $2.11
  • Resistance Level
  • ASMB $14.25
  • SHIM $2.61
  • Average True Range (ATR)
  • ASMB 0.60
  • SHIM 0.12
  • MACD
  • ASMB -0.10
  • SHIM -0.04
  • Stochastic Oscillator
  • ASMB 35.11
  • SHIM 16.98

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About SHIM Shimmick Corporation

Shimmick Corp is a leading provider of water and other critical infrastructure solutions nationwide. It selectively focuses on the following types of infrastructure projects: Water Treatment, Water Resources, and Other Critical Infrastructure. In water treatment projects the company expands, rehabilitates, upgrades, builds and rebuilds water and wastewater treatment infrastructure, including desalination plants. In water resources projects company builds, expands, and improves water storage and conveyance, dams, levees, flood control systems, pump stations, and coastal protection. In Other Critical Infrastructure projects, It builds, retrofits, expands, rehabilitates, operates, and maintains its nation's critical infrastructure, including mass transit, bridges, and military infrastructure.

Share on Social Networks: